$3.17
-0.05-1.55%
Ultimo aggiornamento: Nov 24, 11:50 AM
Comments
Loading...
Report sulle vendite allo scoperto
Il short interest su Lyra Therapeutics Inc (NASDAQ:LYRA) è diminuito durante l'ultimo periodo di rilevazione, aumentando da 37.93K a 23.37K. Questo rappresenta il 1.7% delle azioni disponibili pubblicamente dell'azienda.
Sulla base del volume medio recente di 19.65K azioni scambiate al giorno, ci vorrebbero 1.19 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
23.37K
Vendite allo scoperto %
1.70%
Giorni di copertura
1.19
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
LYRA | Lyra Therapeutics, Inc. Common | 10/31/2025 | 11/11/2025 | 1.70% | 1,378,316 | 23,373 | 19,649 | 1.19 | |
LYRA | Lyra Therapeutics, Inc. Common | 10/15/2025 | 10/24/2025 | 2.75% | 1,378,316 | 37,933 | 73,937 | 1 | |
LYRA | Lyra Therapeutics, Inc. Common | 09/30/2025 | 10/09/2025 | 1.78% | 1,378,316 | 24,582 | 13,659 | 1.8 | |
LYRA | Lyra Therapeutics, Inc. Common | 09/15/2025 | 09/24/2025 | 2.22% | 1,378,316 | 30,562 | 22,027 | 1.39 | |
LYRA | Lyra Therapeutics, Inc. Common | 08/29/2025 | 09/10/2025 | 3.31% | 1,378,316 | 45,602 | 7,298 | 6.25 | |
LYRA | Lyra Therapeutics, Inc. Common | 08/15/2025 | 08/26/2025 | 3.66% | 1,378,316 | 50,503 | 22,808 | 2.21 | |
LYRA | Lyra Therapeutics, Inc. Common | 07/31/2025 | 08/11/2025 | 3.42% | 1,332,238 | 45,614 | 36,250 | 1.26 | |
LYRA | Lyra Therapeutics, Inc. Common | 07/15/2025 | 07/24/2025 | 3.36% | 1,482,578 | 49,858 | 56,737 | 1 | |
LYRA | Lyra Therapeutics, Inc. Common | 06/30/2025 | 07/10/2025 | 8.36% | 1,482,578 | 123,908 | 195,561 | 1 | |
LYRA | Lyra Therapeutics, Inc. Common | 06/13/2025 | 06/25/2025 | 10.74% | 1,059,206 | 113,755 | 3,704,284 | 1 | |
LYRA | Lyra Therapeutics, Inc. Common | 05/30/2025 | 06/10/2025 | 7.79% | 1,059,206 | 82,523 | 84,112 | 1 | |
LYRA | Lyra Therapeutics, Inc. Common | 05/15/2025 | 05/27/2025 | 13.84% | 52,960,344 | 7,328,377 | 10,086,621 | 1 | |
LYRA | Lyra Therapeutics, Inc. Common | 04/30/2025 | 05/09/2025 | 5.10% | 52,960,344 | 2,702,380 | 2,200,488 | 1.23 | |
LYRA | Lyra Therapeutics, Inc. Common | 04/15/2025 | 04/25/2025 | 4.22% | 52,573,680 | 2,218,877 | 2,189,629 | 1.01 | |
LYRA | Lyra Therapeutics, Inc. Common | 03/31/2025 | 04/09/2025 | 4.59% | 52,573,680 | 2,412,416 | 791,849 | 3.05 | |
LYRA | Lyra Therapeutics, Inc. Common | 03/14/2025 | 03/25/2025 | 4.57% | 52,573,680 | 2,402,731 | 936,263 | 2.57 | |
LYRA | Lyra Therapeutics, Inc. Common | 02/28/2025 | 03/11/2025 | 3.58% | 52,483,766 | 1,877,045 | 891,376 | 2.11 | |
LYRA | Lyra Therapeutics, Inc. Common | 02/14/2025 | 02/26/2025 | 4.13% | 52,483,766 | 2,165,753 | 1,095,355 | 1.98 | |
LYRA | Lyra Therapeutics, Inc. Common | 01/31/2025 | 02/11/2025 | 4.07% | 52,483,766 | 2,138,172 | 645,424 | 3.31 | |
LYRA | Lyra Therapeutics, Inc. Common | 01/15/2025 | 01/27/2025 | 4.06% | 52,483,766 | 2,132,249 | 1,811,481 | 1.18 | |
LYRA | Lyra Therapeutics, Inc. Common | 12/31/2024 | 01/10/2025 | 4.01% | 52,483,766 | 2,104,563 | 2,065,277 | 1.02 | |
LYRA | Lyra Therapeutics, Inc. Common | 12/13/2024 | 12/24/2024 | 3.50% | 52,483,766 | 1,837,563 | 1,279,088 | 1.44 | |
LYRA | Lyra Therapeutics, Inc. Common | 11/29/2024 | 12/10/2024 | 4.20% | 52,483,766 | 2,202,963 | 3,152,355 | 1 | |
LYRA | Lyra Therapeutics, Inc. Common | 11/15/2024 | 11/26/2024 | 4.53% | 52,483,766 | 2,378,932 | 1,960,628 | 1.21 | |
LYRA | Lyra Therapeutics, Inc. Common | 10/31/2024 | 11/11/2024 | 3.89% | 52,482,853 | 2,040,864 | 2,011,683 | 1.01 | |
LYRA | Lyra Therapeutics, Inc. Common | 10/15/2024 | 10/24/2024 | 4.08% | 52,482,853 | 2,140,610 | 570,327 | 3.75 | |
LYRA | Lyra Therapeutics, Inc. Common | 09/30/2024 | 10/09/2024 | 5.44% | 52,482,853 | 2,854,202 | 572,351 | 4.99 | |
LYRA | Lyra Therapeutics, Inc. Common | 09/13/2024 | 09/24/2024 | 5.98% | 52,482,853 | 3,138,882 | 728,128 | 4.31 | |
LYRA | Lyra Therapeutics, Inc. Common | 08/30/2024 | 09/11/2024 | 5.65% | 52,482,853 | 2,962,989 | 896,752 | 3.3 | |
LYRA | Lyra Therapeutics, Inc. Common | 07/31/2024 | 08/09/2024 | 7.29% | 47,990,977 | 3,497,576 | 999,552 | 3.5 | |
LYRA | Lyra Therapeutics, Inc. Common | 07/15/2024 | 07/24/2024 | 7.75% | 47,990,977 | 3,717,940 | 1,261,538 | 2.95 | |
LYRA | Lyra Therapeutics, Inc. Common | 06/28/2024 | 07/10/2024 | 4.14% | 47,990,977 | 1,986,361 | 2,877,074 | 1 | |
LYRA | Lyra Therapeutics, Inc. Common | 06/14/2024 | 06/26/2024 | 3.23% | 47,990,977 | 1,547,959 | 1,487,896 | 1.04 | |
LYRA | Lyra Therapeutics, Inc. Common | 05/31/2024 | 06/11/2024 | 1.88% | 47,990,977 | 902,209 | 2,727,369 | 1 | |
LYRA | Lyra Therapeutics, Inc. Common | 05/15/2024 | 05/24/2024 | 1.26% | 47,990,977 | 603,031 | 14,075,341 | 1 | |
LYRA | Lyra Therapeutics, Inc. Common | 04/30/2024 | 05/09/2024 | 0.86% | 47,990,977 | 413,791 | 231,174 | 1.79 | |
LYRA | Lyra Therapeutics, Inc. Common | 04/15/2024 | 04/24/2024 | 0.70% | 47,990,977 | 333,557 | 430,649 | 1 | |
LYRA | Lyra Therapeutics, Inc. Common | 03/28/2024 | 04/09/2024 | 0.55% | 40,822,825 | 223,030 | 583,113 | 1 | |
LYRA | Lyra Therapeutics, Inc. Common | 03/15/2024 | 03/26/2024 | 0.51% | 40,822,825 | 206,266 | 272,559 | 1 | |
LYRA | Lyra Therapeutics, Inc. Common | 02/29/2024 | 03/11/2024 | 0.39% | 40,822,825 | 160,225 | 409,968 | 1 | |
LYRA | Lyra Therapeutics, Inc. Common | 02/15/2024 | 02/27/2024 | 0.48% | 39,035,947 | 185,432 | 290,438 | 1 | |
LYRA | Lyra Therapeutics, Inc. Common | 01/31/2024 | 02/09/2024 | 0.33% | 39,035,947 | 129,206 | 145,712 | 1 | |
LYRA | Lyra Therapeutics, Inc. Common | 01/12/2024 | 01/24/2024 | 0.35% | 39,035,947 | 136,904 | 218,416 | 1 | |
LYRA | Lyra Therapeutics, Inc. Common | 12/29/2023 | 01/10/2024 | 0.45% | 39,035,947 | 176,839 | 162,424 | 1.09 | |
LYRA | Lyra Therapeutics, Inc. Common | 12/15/2023 | 12/27/2023 | 0.44% | 39,035,947 | 172,627 | 269,868 | 1 | |
LYRA | Lyra Therapeutics, Inc. Common | 11/30/2023 | 12/11/2023 | 0.58% | 39,035,947 | 228,259 | 143,345 | 1.59 | |
LYRA | Lyra Therapeutics, Inc. Common | 11/15/2023 | 11/27/2023 | 0.68% | 39,035,947 | 265,234 | 382,768 | 1 |
In cerca di azioni più vendute allo scoperto?